About Ibex Medical Analytics
Ibex Medical Analytics provides AI-powered diagnostic solutions that help pathologists ensure better cancer care for patients around the world.
Mission & Story
Mission
To transform pathology by ensuring that every patient can receive an accurate, timely and personalized cancer diagnosis
Founding Story
Founded in 2016 with the mission to transform cancer diagnostics through AI. The company set out to ensure every patient receives accurate, timely, and personalized cancer diagnosis. Developed by pathologists for pathologists from the ground up.
Clinical Focus
Medical conditions and clinical areas addressed by Ibex Medical Analytics.
Who It Serves
Milestones & Awards
Recent Milestones
Expansion into biopharma for early translational research and biomarker development. Partnership expansion with Philips. Collaboration with Roche and AWS. Series B funding of $38 million mentioned.
Awards & Recognition
Described as 'worldwide leader in live clinical rollouts' and 'most widely-deployed AI platform in pathology'
Key Partnerships
Social & Media
Follow on
Latest Updates
Ibex Medical Analytics and mTuitive Announce Strategic Partnership to Transform Digital Pathology with AI-Enhanced Structured Reporting
Ibex Expands U.S. Footprint with HNL Lab Medicine Partnership to Deploy Clinical-Grade AI to Support Cancer Diagnostics
Ibex Medical Analytics Establishes Biopharma Advisory Board to Advance AI-Powered Precision Diagnostics
Ibex Medical Analytics Unveils Ibex 4, the Next-Generation AI Platform Setting a New Standard in Comprehensive Cancer Diagnostics and Patient Care
CorePlus and Ibex Expand Partnership with Clinical Deployment of AI-Powered Diagnostics for TURP
Company Details
- Founded
- 2016
- Headquarters
- Tel Aviv, Israel
- Employees
- 150
- Stage
- series c
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 45 →
Aiforia
Aiforia provides AI-powered digital pathology solutions for clinical diagnostics and research. The company offers cloud-based deep learning tools and CE-IVD marked clinical suites for analyzing pathology images across multiple cancer types, serving pathologists, researchers, and diagnostic laboratories worldwide.
Aignostics
Aignostics develops AI-powered pathology solutions for precision medicine, specializing in tumor microenvironment analysis from H&E-stained whole slide images. The company serves life sciences companies and academic researchers with foundation models and custom analytics services.
Aiosyn
Aiosyn develops AI-powered computational pathology software that integrates into standard digital pathology workflows. The company specializes in deep learning solutions for cancer and chronic kidney disease diagnostics, serving clinical laboratories, biopharma, and CROs.
AIxMed
AIxMed develops AI-powered computational cytology platforms for cancer detection and diagnosis. The company's flagship product AIxURO analyzes urine cytology for bladder cancer, with additional platforms in development for thyroid, cervical, and lung cancer screening.
Akoya Biosciences
Akoya Biosciences, now part of Quanterix, provides spatial biology solutions for high-plex tissue analysis. The company develops instruments, assays, and software for spatial proteomics research, enabling researchers to map biomarkers at single-cell resolution in tissue samples.
Caris Life Sciences
Caris Life Sciences is a leading precision medicine company that provides comprehensive molecular profiling for cancer patients. The company combines genomic, transcriptomic, and proteomic data with AI to deliver personalized treatment insights for oncologists and patients.
CellaVision
201-500 employees
CellaVision is a world-leading provider of digital hematology microscopy solutions covering analyzers, instruments, reagents, and software. The company automates workflows in hematology laboratories of all sizes for human and animal blood and body fluid sample analysis.
Clever Culture Systems
Clever Culture Systems develops AI-powered automated microbiology culture plate reading technology for pharmaceutical and clinical laboratories. Their flagship product, APAS Independence, automates the imaging, interpretation, and reporting of microbial growth on culture plates.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.